MetLife Investment Management’s Evolv Technologies EVLV Stock Holding History

MetLife Investment Management’s Portfolio EVLV Stock Details EVLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$459K	Sell	75,830 -9,647	-11%	-$56.5K	﹤0.01%	1795
2025 Q4	$612K	Buy	85,477 +15,066	+21%	+$107K	﹤0.01%	1699
2025 Q3	$532K	Sell	70,411 -3,477	-5%	-$25.4K	﹤0.01%	1778
2025 Q2	$461K	Sell	73,888 -17,154	-19%	-$79.4K	﹤0.01%	1714
2025 Q1	$284K	Buy	91,042 +4,412	+5%	+$15.5K	﹤0.01%	2005
2024 Q4	$342K	Buy	86,630 +9,575	+12%	+$33.6K	﹤0.01%	2003
2024 Q3	$312K	Buy	77,055 +5,090	+7%	+$17.8K	﹤0.01%	2045
2024 Q2	$184K	Buy	71,965 +22,951	+47%	+$76K	﹤0.01%	2307
2024 Q1	$218K	Sell	49,014 -11,366	-19%	-$49.1K	﹤0.01%	2159
2023 Q4	$285K	Hold	60,380	–	–	﹤0.01%	2035
2023 Q3	$293K	Hold	60,380	–	–	﹤0.01%	1971
2023 Q2	$362K	Buy	60,380 +11,341	+23%	+$53.6K	﹤0.01%	1907
2023 Q1	$153K	Hold	49,039	–	–	﹤0.01%	2372
2022 Q4	$127K	Hold	49,039	–	–	﹤0.01%	2493
2022 Q3	$104K	Hold	49,039	–	–	﹤0.01%	2671
2022 Q2	$130K	Buy	+49,039	New	+$130K	﹤0.01%	2582

Other funds holding EVLV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SPCM

Stoic Point Capital Management Palo Alto, California $103M AUM

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MetLife Investment Management's EVLV Position: Q1 2026 in Review

MetLife Investment Management reduced its Evolv Technologies (EVLV) stake by 11% in Q1 2026, selling an estimated $56.5K and leaving 75,830 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

MetLife Investment Management first reported a position in EVLV in Q2 2022 and has held it in 16 quarters since. The position peaked at $612K in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

MetLife Investment Management held 75,830 shares of Evolv Technologies worth $459K as of Q1 2026.
MetLife Investment Management sold 9,647 Evolv Technologies shares in Q1 2026, an estimated $56.5K.
Evolv Technologies made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1795 holding.
MetLife Investment Management first reported a position in Evolv Technologies in Q2 2022 and has held it in 16 quarters since.
MetLife Investment Management's Evolv Technologies position peaked at $612K in Q4 2025.
260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.